Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer
2012 · Cancer Discovery · 871 citations
https://doi.org/10.1158/2159-8290.cd-12-0349
X
X. Cynthia
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
638
Papers
16.9K
Citations
66
h-index
198
i10-index
X. Cynthia is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Advanced Breast Cancer Therapies & HER2/EGFR in Cancer Research & Cancer Treatment and Pharmacology. The author has an h-index of 66, co-authored 543 publications.
ORCID: 0000-0002-8156-7492Papers by this author
worksEndocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts
2013 · Cell Reports · 613 citations
https://doi.org/10.1016/j.celrep.2013.08.022
64Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer
2017 · Clinical Cancer Research · 360 citations
https://doi.org/10.1158/1078-0432.ccr-16-3193
NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor–Positive Breast Cancer
2017 · Clinical Cancer Research · 359 citations
https://doi.org/10.1158/1078-0432.ccr-16-3206
Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to estrogen receptor–directed therapies
2018 · Nature Genetics · 235 citations
https://doi.org/10.1038/s41588-018-0287-5
Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer
2011 · Breast Cancer Research · 184 citations
https://doi.org/10.1186/bcr2833
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat